Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rhythm Pharmaceuticals Inc (NQ: RYTM )

38.87 -0.30 (-0.76%)
Streaming Delayed Price Updated: 9:41 AM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rhythm Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 7 8 Next >
AeroVironment, Snap And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Rhythm Secures European Commission Marketing Authorization For Genetic Disease Candidate
The European Commission (EC) has expanded the marketing authorization for Rhythm’s (NASDAQ: RYTM) lead drug product IMCIVREE (setmelanotide) to include the treatment of obesity and control of hunger... 
Via Benzinga
Jim Cramer Says He's Passing On This $10 Social Media Stock As It's 'Losing Money'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a "very interesting company. 
Via Benzinga
Why Goldman Sachs Raised Its Price Target On This Biotech Stock By Nearly 5X
The initial phase II data in patients with hypothalamic obesity (HO) has transformed the opportunity for Rhythm Pharmaceuticals Inc’s (NASDAQ: RYTM) Imcivree, according to Goldman Sachs. 
Via Benzinga
Rhythm Pharma Outlines Robust Start To Newly Approved Drug For Genetic Condition
Via Benzinga
Why Shares Of Rhythm Pharmaceuticals Are Soaring
Rhythm Pharmaceuticals, Inc. 
Via Benzinga
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month. 
Via Benzinga
Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
Upgrades 
Via Benzinga
Moderna, PayPal And Some Other Big Gainers From Wednesday
U.S. stocks closed higher on Wednesday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume. 
Via Benzinga
What 7 Analyst Ratings Have To Say About Rhythm Pharmaceuticals
Over the past 3 months, 7 analysts have published their opinion on Rhythm Pharmaceuticals (NASDAQ:RYTM) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital. 
Via Benzinga
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks. 
Via Benzinga
Why U.S. Stocks Are Trading Lower; Job Openings Drop To This Level In June
U.S. stocks traded lower this morning, with the Dow Jones falling more than 250 points on Tuesday. 
Via Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Rhythm Pharmaceuticals: Q2 Earnings Insights
  Rhythm Pharmaceuticals (NASDAQ:RYTM) reported its Q2 earnings results on Tuesday, August 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Rhythm Pharmaceuticals's Earnings: A Preview
Rhythm Pharmaceuticals (NASDAQ:RYTM) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion. 
Via Benzinga
Recap Of Friday's Biotech Catalysts - End Of The Day Summary
Via Benzinga
Rhythm Has Tripled In A Week And Quintupled Since May — Here's Why
The company looks to take on behemoths Novo Nordisk and Eli Lilly in obesity drugs. 
Via Investor's Business Daily
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022. 
Via Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
  
Via Benzinga
Stocks Shift Higher as Strong Earnings Continue
The broader market has rebounded from this morning's losses midday. 
Via Talk Markets
This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session
Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year... 
Via Benzinga
Tech Shares Move Higher, Nasdaq Jumps 200 Points
U.S. stocks traded higher midway through trading, with the NASDAQ Composite gaining more than 200 points on Wednesday. 
Via Benzinga
Rhythm Shares Shoot Higher Following Pre-marketing Authorization From French Regulatory For Multisystem Disorder Candidate
The French National Agency for Medicines and Health Products Safety (ANSM) and Haute Autorité de santé (HAS) have granted pre-marketing authorization AP1 (early access authorization), for Rhythm... 
Via Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.